Weight loss is not enough to treat dyslipidemia in women

Published Date: 06 Mar 2023

Obesity continues to exist around the world despite the risk to health and death from illness and disease.

Read Full News

Latest News

CagriSema Boosts Weight Loss, A1c Benefits in T2D

The novel combination of the two therapies shows improved effects vs either drug alone, without increases in side effects.

Heat-Related CVD Burden May Nearly Triple by 2050

Rising temperatures are projected to nearly triple the burden of cardiovascular disease in the US by 2050 under a scenario of high emissions of greenhouse gases, a study estimates.

Stroke Treatment Outcomes Vary by Cancer Subtype

Patients with cancer who suffer an acute ischaemic stroke face higher odds of in-hospital death and bleeding after recanalisation therapy, with outcomes varying by cancer subtypes.

Lung Ultrasound Plus CRP May Guide Antibiotic Decisions

Lung ultrasound may help identify a bacterial component in children with acute lower respiratory tract infections and may guide antibiotic decisions when paired with C-reactive protein.

Serum Potassium Concentrations Shape Heart Failure Risk

A meta-analysis identifies the optimal serum potassium range linked to a lower risk for death and hospitalisation in heart failure, with low potassium tied to worse outcomes in HFrEF.

Semaglutide Accepted in Scotland for CV Risk Reduction

The SMC accepted semaglutide for adults with established cardiovascular disease and overweight or obesity, expanding its role beyond weight management.

Todays Updates

FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets

The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

Highlights in Prostate Cancer From AUA 2026

Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

New Imaging Agent Could Speed Detection of AD-Related Tau

A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.

CMS Rule Misses Mark on CPAP Adherence

A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.

Good Outcomes with Ublituximab in First Real-World Study

Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Todays Updates

FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets

The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

Highlights in Prostate Cancer From AUA 2026

Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

New Imaging Agent Could Speed Detection of AD-Related Tau

A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.

CMS Rule Misses Mark on CPAP Adherence

A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.

Good Outcomes with Ublituximab in First Real-World Study

Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Latest News

The novel combination of the two therapies shows improved effects vs either drug alone, without increases in side effects.

Rising temperatures are projected to nearly triple the burden of cardiovascular disease in the US by 2050 under a scenario of high emissions of greenhouse gases, a study estimates.

Patients with cancer who suffer an acute ischaemic stroke face higher odds of in-hospital death and bleeding after recanalisation therapy, with outcomes varying by cancer subtypes.

Lung ultrasound may help identify a bacterial component in children with acute lower respiratory tract infections and may guide antibiotic decisions when paired with C-reactive protein.

A meta-analysis identifies the optimal serum potassium range linked to a lower risk for death and hospitalisation in heart failure, with low potassium tied to worse outcomes in HFrEF.

The SMC accepted semaglutide for adults with established cardiovascular disease and overweight or obesity, expanding its role beyond weight management.

News All Time

Hidden Heart Disease Found in At-Risk Communities

Silent MIs and undiagnosed heart disease were common in deprived and ethnically diverse communities — found via primary care and social media.

Mortality Predictors in Vasculitis With Kidney Involvement

Among patients with ANCA-positive vasculitis and severe kidney involvement, older age and low serum albumin levels at diagnosis are independent predictors of long-term mortality.

Teen Fitness Tied to Early AF Risk, Later CVD Benefit

In men, high adolescent cardiorespiratory fitness is linked to a small excess risk for atrial fibrillation in early adulthood but larger reductions in the risk for other cardiovascular events later on.

Is At-Home, Extended-Release Ketamine Coming to Market Soon?

A new take-home tablet is in development, but will the features that make it attractive blunt the experience that could be part of ketamine’s therapeutic value?

Weight Loss May Not Ease Symptoms of AF in Older Patients

A low-calorie diet program may facilitate significant weight loss among older patients with persistent atrial fibrillation, but this may not translate into reduced severity of disease symptoms.

Zurich Heart Surgery Scandal: Device Safety Alert

An independent inquiry links roughly 70 excess deaths at Zurich’s university heart clinic (2016-2020); prosecutors now probe valve-implant use, raising device-safety concerns.

Women Underreferred for Advanced Heart Failure Care

Women in the UK and Ireland account for just 1 in 3 advanced heart failure referrals, despite similar disease burden, an audit finds.

Drug Interactions Common With DOACs in AF

Drug-drug interactions with direct oral anticoagulants are common in Belgian primary care, affecting nearly 1 in 4 patients with non-valvular atrial fibrillation over a year.

Robotic Mitral Valve Surgery Shows Durable Results

Robotic mitral valve repair achieved excellent long-term durability and shortened ICU and hospital stays compared with endoscopic surgery.

Prasugrel Outshines Rival Drugs After Invasive Coronary Care

Among commonly used antiplatelet agents, prasugrel offers the most optimal balance between efficacy and safety after invasive management of patients with coronary syndrome, a meta-analysis finds.

Planetary Health Diet May Lower Obesity Risk at Menopause

The planetary health and low-insulinemic diets — rich in plants and whole grains and low in red and processed meats and fried foods — can aid weight management during menopause, a recent study shows.

Food Additives: Is New Evidence Raising Safety Questions?

Large cohort studies link several food colorings and preservatives to higher risks for diabetes, cancer, hypertension, and cardiovascular disease.

FDA-Cleared ACORYS: Catheter-Free Cardiac Mapping

Noninvasive mapping with hundreds of body surface electrodes transforms the inverse ECG problem, letting AI and models infer intracardiac activation without catheter insertion.

Cycling Linked to Higher Arrhythmia Risk in Middle-Aged Men

More hours of lifetime endurance exercise are linked to increased odds of reporting atrial fibrillation or atrial flutter in middle aged men, and cycling shows an independent association.

Home Cardiac Rehab Data Signal Wider Access Gains

Home-based digital cardiac rehab platforms are reaching women, ethnic minorities, and deprived communities missed by conventional services, new data show.

Proteinuria in Preeclampsia Tied to Hypertension & CKD Risks

Among women with preeclampsia, high levels of urinary protein excretion are associated with increased long-term risks for hypertension and chronic kidney disease.

Recommended News For You

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

How 7,000 steps a day could help reduce your risk of cancer

FDA Expands Approval of Osimertinib in Lung Cancer

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Fighting for others: How guilt and obligation drive desire for more intensive treatments in end-of-life cancer care

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

The Kansas Cancer Center awarded two Indian American doctors professorships.

Recommended Articles For You

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options  

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

Comprehensive Developments in Hematology in Daily Practice 

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals

2.

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

3.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

4.

Glofitamab Regimen Improves Survival in DLBCL

5.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

1.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

2.

Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes

3.

Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia

4.

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer

5.

How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot